Automate Your Wheel Strategy on PRPO
With Tiblio's Option Bot, you can configure your own wheel strategy including PRPO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PRPO
- Rev/Share 12.8819
- Book/Share 7.7849
- PB 1.8228
- Debt/Equity 0.1849
- CurrentRatio 0.7569
- ROIC -0.2154
- MktCap 21455422.0
- FreeCF/Share 0.4665
- PFCF 30.6069
- PE -6.8894
- Debt/Assets 0.1216
- DivYield 0
- ROE -0.2587
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About Precipio, Inc. (PRPO)
- IPO Date 2017-06-30
- Website https://www.precipiodx.com
- Industry Medical - Diagnostics & Research
- CEO Ilan Danieli
- Employees 54
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.